Literature DB >> 35720240

Digestive involvement in the Long-COVID syndrome.

Alina M Bogariu1, Dan L Dumitrascu1.   

Abstract

Background and aim: The SARS-CoV-2 infection which caused a worldwide epidemic was considered first a lung disease. Later on, it was found that the disease caused by this virus, SARS-CoV-2, can affect most organs, including the digestive system. The long-term effects of this infection are now progressively detected and called Long-COVID. This review aims is to present the updated knowledge of the digestive sequelae after SARS-CoV-2 infection.
Methods: A search was performed in the main medical literature databases. The following search terms were used: long-covid, gastrointestinal or gastric sequelae SARS-CoV-2 and COVID-19. Data on gastrointestinal symptoms after 12 weeks were collected and presented. Observational studies were included. Studies that focus only on acute COVID-19 infection (<4 weeks) were excluded.
Results: The main symptoms that can occur in the long term are: diarrhea, nausea, vomiting, abdominal pain, along with increased liver enzymes. Patients with chronic diseases have a higher risk of developing long-term sequelae, but it is not documented that digestive sequelae are influenced by the presence of chronic diseases. Conclusions: The SARS-CoV-2 virus can affect any part of the digestive system not only in the acute infection phase but also for longer time, leaving long-term sequelae.

Entities:  

Keywords:  COVID-19; SARS-Cov-2 infection; digestive diseases; gastrointestinal tract; liver diseases; long-Covid; sequelae

Year:  2022        PMID: 35720240      PMCID: PMC9177081          DOI: 10.15386/mpr-2340

Source DB:  PubMed          Journal:  Med Pharm Rep        ISSN: 2602-0807


  23 in total

1.  High-dimensional characterization of post-acute sequelae of COVID-19.

Authors:  Ziyad Al-Aly; Yan Xie; Benjamin Bowe
Journal:  Nature       Date:  2021-04-22       Impact factor: 49.962

2.  Post-COVID-19 Cholangiopathy: A Novel Entity.

Authors:  Nitzan C Roth; Angela Kim; Taisia Vitkovski; Jianxiang Xia; Guillermo Ramirez; David Bernstein; James M Crawford
Journal:  Am J Gastroenterol       Date:  2021-05-01       Impact factor: 10.864

Review 3.  Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

Authors:  Daniel P Oran; Eric J Topol
Journal:  Ann Intern Med       Date:  2020-06-03       Impact factor: 25.391

4.  Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.

Authors:  Ren Mao; Yun Qiu; Jin-Shen He; Jin-Yu Tan; Xue-Hua Li; Jie Liang; Jun Shen; Liang-Ru Zhu; Yan Chen; Marietta Iacucci; Siew C Ng; Subrata Ghosh; Min-Hu Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05-12

5.  Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.

Authors:  Francisco A Durazo; Allyssa A Nicholas; Jennifer J Mahaffey; Shannon Sova; John J Evans; Juan Pablo Trivella; Veronica Loy; Joohyun Kim; Michael A Zimmerman; Johnny C Hong
Journal:  Transplant Proc       Date:  2021-03-12       Impact factor: 1.066

Review 6.  Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.

Authors:  Dan-Cristian Vodnar; Laura Mitrea; Bernadette-Emoke Teleky; Katalin Szabo; Lavinia-Florina Călinoiu; Silvia-Amalia Nemeş; Gheorghe-Adrian Martău
Journal:  Front Cell Infect Microbiol       Date:  2020-12-09       Impact factor: 5.293

7.  Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers.

Authors:  Abdul Mannan Baig
Journal:  J Med Virol       Date:  2021-03-01       Impact factor: 2.327

8.  Long COVID and chronic COVID syndromes.

Authors:  Stephen Halpin; Rory O'Connor; Manoj Sivan
Journal:  J Med Virol       Date:  2020-10-30       Impact factor: 20.693

9.  Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?

Authors:  L Z Chen; Z H Lin; J Chen; S S Liu; T Shi; Y N Xin
Journal:  Epidemiol Infect       Date:  2020-09-21       Impact factor: 2.451

10.  Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.

Authors:  Andrea Dennis; Malgorzata Wamil; Johann Alberts; Jude Oben; Daniel J Cuthbertson; Dan Wootton; Michael Crooks; Mark Gabbay; Michael Brady; Lyth Hishmeh; Emily Attree; Melissa Heightman; Rajarshi Banerjee; Amitava Banerjee
Journal:  BMJ Open       Date:  2021-03-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.